Mapping the Future of Hematological Malignancy Research with OGM: Discoveries in Leukemia and Lymphomas

Wednesday, November 20, 2024

10:00 AM – 10:50 AM PST

Location: 215 & 216, Level 2

Corporate Workshop Speaker(s)

AH

Alex Hastie

VP of Clinical and Scientific Affairs
Bionano
Susan Crocker, PhD, FCCMG, FACMG

Director of Cytogenetics
Kingston Health Sciences Centre
Kingston, Ontario, Canada
Gokce Toruner, MD, PhD

Clinical Laboratory Geneticist
MD Anderson
Houston, Texas, United States
TT

Tracy Tucker, PhD, FCCMG

Clinical Professor and Clinical Laboratory Geneticist
University of British Columbia and BC Cancer Center

This session explores the groundbreaking use of optical genome mapping (OGM) in identifying and understanding hematologic malignancies. Dr. Susan Crocker will focus on how OGM aids in the analysis of Acute Myeloid Leukemia (AML), presenting case studies where VIA interpretation software provides comprehensive genomic profiles. Dr. Tracy Tucker will present on OGM’s effectiveness in detecting genetic abnormalities in Chronic Lymphocytic Leukemia (CLL), highlighting advantages over traditional methods and the impact of findings. Additionally, Dr. Gokce Toruner will share extensive clinical research, detailing results from over 500 hematologic malignancy samples that utilized OGM for better genetic insights. The session will close with a Q&A session led by Dr. Alex Hastie, Vice President of Clinical and Scientific Affairs at Bionano.